SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Amdocs Limited (DOX) trades at a trailing P/E of 12.3, forward P/E of 8.7. Trailing earnings yield is 8.14%, forward earnings yield 11.47%. PEG 0.65 (Peter Lynch undervalued ≤1.0). Graham Number is $61.45.
Criteria proven by this page:
- VALUE (66/100, Pass) — P/E is below market average (12.3); PEG ≤ 1.0 — Peter Lynch undervalued (0.65); analyst target implies upside (+38.5%); earnings yield beats bond yields (8.14%).
- Forward P/E 8.7 (down from trailing 12.3) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.65 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 8.14% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 11.47% as earnings recover.
- Analyst consensus target $90.00 (+38.5% upside) — significant upside potential according to Wall Street analysts.
Overall SharesGrow Score: 66/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
66/100
Price-to-Earnings & upside
Proven by this page
✓
HEALTH
83/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DOX
Valuation Multiples
P/E (TTM)12.3
Forward P/E8.7
PEG Ratio0.65
Forward PEG0.18
P/B Ratio2.05
P/S Ratio1.52
EV/EBITDA8.1
Per Share Data
EPS (TTM)$5.26
Forward EPS (Est.)$7.45
Book Value / Share$31.89
Revenue / Share$42.14
FCF / Share$6.95
Yields & Fair Value
Earnings Yield8.14%
Forward Earnings Yield11.47%
Dividend Yield3.33%
Graham Number$61.45
SharesGrow IV$178.35 (+174.5%)
Analyst Target$90.00 (+38.5%)
Historical Valuation
| Year |
P/E (TTM) |
PEG Ratio |
P/B Ratio |
P/S Ratio |
Dividend Yield |
| 2016 |
21.1 |
-4.06 |
2.50 |
2.32 |
1.27% |
| 2017 |
21.5 |
2.36 |
2.63 |
2.43 |
1.29% |
| 2018 |
26.4 |
-1.58 |
2.71 |
2.35 |
1.44% |
| 2019 |
18.8 |
0.47 |
2.58 |
2.21 |
1.64% |
| 2020 |
15.3 |
2.22 |
2.10 |
1.83 |
2.16% |
| 2021 |
14.0 |
0.32 |
2.68 |
2.25 |
1.84% |
| 2022 |
17.5 |
-1.05 |
2.73 |
2.10 |
1.93% |
| 2023 |
18.4 |
16.44 |
2.82 |
2.03 |
2.01% |
| 2024 |
20.1 |
-3.63 |
2.87 |
1.98 |
2.14% |
| 2025 |
16.1 |
0.85 |
2.66 |
2.01 |
2.46% |
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$2.71 |
$3.72B |
$409.33M |
11% |
| 2017 |
$2.96 |
$3.87B |
$436.83M |
11.3% |
| 2018 |
$2.47 |
$3.97B |
$354.4M |
8.9% |
| 2019 |
$3.47 |
$4.09B |
$479.45M |
11.7% |
| 2020 |
$3.71 |
$4.17B |
$497.84M |
11.9% |
| 2021 |
$5.32 |
$4.29B |
$688.37M |
16.1% |
| 2022 |
$4.44 |
$4.58B |
$549.5M |
12% |
| 2023 |
$4.49 |
$4.89B |
$540.71M |
11.1% |
| 2024 |
$4.25 |
$5B |
$493.2M |
9.9% |
| 2025 |
$5.05 |
$4.53B |
$564.7M |
12.5% |
Analyst Estimates
| Year |
EPS (Avg) |
EPS Range |
Revenue (Avg) |
Revenue Range |
Analysts |
| 2026 |
$7.45 |
$7.39 – $7.54 |
$4.69B |
$4.65B – $4.7B |
4 |
| 2027 |
$8.09 |
$7.95 – $8.25 |
$4.85B |
$4.81B – $4.86B |
4 |
| 2028 |
$9.02 |
$8.94 – $9.06 |
$5.08B |
$5.06B – $5.1B |
1 |
| 2029 |
$9.79 |
$9.70 – $9.83 |
$5.28B |
$5.24B – $5.3B |
1 |
| 2030 |
$10.62 |
$10.52 – $10.66 |
$5.49B |
$5.45B – $5.51B |
1 |
